Update on the use of immunoglobulin in human disease: a review of evidence

EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of …

JS Orange, EM Hossny, CR Weiler, M Ballow… - Journal of Allergy and …, 2006 - Elsevier
Human immunoglobulin prepared for intravenous administration (IGIV) has a number of
important uses in the treatment of disease. Some of these are in diseases for which …

Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders [RETIRED] Report of the Therapeutics and Technology …

HS Patwa, V Chaudhry, H Katzberg, AD Rae-Grant… - Neurology, 2012 - AAN Enterprises
Objective: To assess the evidence for the efficacy of IV immunoglobulin (IVIg) to treat
neuromuscular disorders. Methods: The MEDLINE, Web of Science, and EMBASE …

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the …

Joint Task Force of the Efns and the … - Journal of the Peripheral …, 2010 - Wiley Online Library
A European Federation of Neurological Societies/Peripheral Nerve Society consensus
guideline on the definition, investigation, and treatment of multifocal motor neuropathy …

Clinical spectrum of chronic acquired demyelinating polyneuropathies

DS Saperstein, JS Katz, AA Amato… - Muscle & Nerve …, 2001 - Wiley Online Library
A number of presentations of chronic demyelinating polyneuropathy have been identified,
each distinguished by its phenotypic pattern. In addition to classic chronic inflammatory …

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in …

I Elovaara, S Apostolski, P Van Doorn… - European Journal of …, 2008 - Wiley Online Library
Despite high‐dose intravenous immunoglobulin (IVIG) is widely used in treatment of a
number of immune‐mediated neurological diseases, the consensus on its optimal use is …

Immune-mediated neuropathies: pathophysiology and management

A Shastri, A Al Aiyan, U Kishore… - International journal of …, 2023 - mdpi.com
Dysfunction of the immune system can result in damage of the peripheral nervous system.
The immunological mechanisms, which include macrophage infiltration, inflammation and …

Intravenous immunoglobulin in autoimmune neuromuscular diseases

MC Dalakas - Jama, 2004 - jamanetwork.com
ContextIntravenous immunoglobulin (IVIG) enhances immune homeostasis by modulating
expression and function of Fc receptors, interfering with activation of complement and …

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study

JM Léger, B Chassande, L Musset, V Meininger… - Brain, 2001 - academic.oup.com
We conducted a double-blind, placebo-controlled, study of 19 patients fulfilling eligibility
criteria for multifocal motor neuropathy with persistent conduction block. They were enrolled …

Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies

L Vlam, W van der Pol, EA Cats, DC Straver… - Nature Reviews …, 2012 - nature.com
Multifocal motor neuropathy (MMN) is a rare inflammatory neuropathy characterized by
slowly progressive, asymmetric distal limb weakness without sensory loss. The clinical …